Dodecyl b-D-glucopyranoside

Catalog No. :
ACBYEW763
CAS No. :
59122-55-3
Molecular Formula :
C18H36O6
Molecular Weight :
348.48

IUPAC Name:(2R,3R,4S,5S,6R)-2-(dodecyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

Dodecyl b-D-glucopyranoside structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$148.00Login to see priceIn stockInquiry
25g98%$516.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDodecyl b-D-glucopyranoside
IUPAC Name(2R,3R,4S,5S,6R)-2-(dodecyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
MDL No.MFCD00063298
Molecular FormulaC18H36O6
Molecular Weight348.48
SMILESO[C@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)[C@@H]1OCCCCCCCCCCCC
InChI KeyPYIDGJJWBIBVIA-UYTYNIKBSA-N
SynonymDODECYL .BETA.-D-GLUCOPYRANOSIDE | D-Glucopyranoside, dodecyl | n-DODECYL-beta-D-GLUCOPYRANOSIDE | (2R,3R,4S,5S,6R)-2-dodecoxy-6-(hydroxymethyl)oxane-3,4,5-triol | Fluorescent Brightener CBS-X | Dodecylb-D-glucopyranoside | RWJ-387252 | Dodecyl b-D-glucop
CAS No.59122-55-3
PubChem CID93321

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBYEW763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDNOZ836 route compound structure diagram
    ACDNOZ8369050-36-6 In Stock
  4. Then
  5. ACBYEW763 route product structure diagram
    ACBYEW76359122-55-3 In Stock
Inquiry

2. ACBYEW763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBYEW763 route product structure diagram
    ACBYEW76359122-55-3 In Stock
Inquiry

Comments (0)